Literature DB >> 17652170

An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor.

Trevor Huyton1, Jian-Guo Zhang, Cindy S Luo, Mei-Zhen Lou, Douglas J Hilton, Nicos A Nicola, Thomas P J Garrett.   

Abstract

Leukemia inhibitory factor (LIF) receptor is a cell surface receptor that mediates the actions of LIF and other IL-6 type cytokines through the formation of high-affinity signaling complexes with gp130. Here we present the crystal structure of a complex of mouse LIF receptor with human LIF at 4.0 A resolution. The structure is, to date, the largest cytokine receptor fragment determined by x-ray crystallography. The binding of LIF to its receptor via the central Ig-like domain is unlike other cytokine receptor complexes that bind ligand predominantly through their cytokine-binding modules. This structure, in combination with previous crystallographic studies, also provides a structural template to understand the formation and orientation of the high-affinity signaling complex between LIF, LIF receptor, and gp130.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652170      PMCID: PMC1937536          DOI: 10.1073/pnas.0705577104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Evidence for the formation of a heterotrimeric complex of leukaemia inhibitory factor with its receptor subunits in solution.

Authors:  J G Zhang; C M Owczarek; L D Ward; G J Howlett; L J Fabri; B A Roberts; N A Nicola
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

3.  Crystal structure of a cytokine-binding region of gp130.

Authors:  J Bravo; D Staunton; J K Heath; E Y Jones
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

4.  Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.

Authors:  Hélène Plun-Favreau; David Perret; Caroline Diveu; Josy Froger; Sylvie Chevalier; Eric Lelièvre; Hugues Gascan; Marie Chabbert
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

5.  A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor.

Authors:  Andreas Timmermann; Andrea Küster; Ingo Kurth; Peter C Heinrich; Gerhard Müller-Newen
Journal:  Eur J Biochem       Date:  2002-06

6.  Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.

Authors:  Georgios Skiniotis; Martin J Boulanger; K Christopher Garcia; Thomas Walz
Journal:  Nat Struct Mol Biol       Date:  2005-05-15       Impact factor: 15.369

7.  Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.

Authors:  Martin J Boulanger; Dar-chone Chow; Elena E Brevnova; K Christopher Garcia
Journal:  Science       Date:  2003-06-27       Impact factor: 47.728

8.  Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130.

Authors:  Martin J Boulanger; Alexander J Bankovich; Tanja Kortemme; David Baker; K Christopher Garcia
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

9.  The dynamics of signal triggering in a gp130-receptor complex.

Authors:  Rishi Matadeen; Wai-Ching Hon; John K Heath; E Yvonne Jones; Stephen Fuller
Journal:  Structure       Date:  2007-04       Impact factor: 5.006

10.  Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death.

Authors:  C B Ware; M C Horowitz; B R Renshaw; J S Hunt; D Liggitt; S A Koblar; B C Gliniak; H J McKenna; T Papayannopoulou; B Thoma
Journal:  Development       Date:  1995-05       Impact factor: 6.868

View more
  33 in total

1.  Birth control vaccine targeting leukemia inhibitory factor.

Authors:  Angela R Lemons; Rajesh K Naz
Journal:  Mol Reprod Dev       Date:  2011-12-02       Impact factor: 2.609

2.  Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes.

Authors:  Yibin Xu; Nadia J Kershaw; Cindy S Luo; Priscilla Soo; Michael J Pocock; Peter E Czabotar; Douglas J Hilton; Nicos A Nicola; Thomas P J Garrett; Jian-Guo Zhang
Journal:  J Biol Chem       Date:  2010-05-20       Impact factor: 5.157

3.  The composition and signaling of the IL-35 receptor are unconventional.

Authors:  Lauren W Collison; Greg M Delgoffe; Clifford S Guy; Kate M Vignali; Vandana Chaturvedi; DeLisa Fairweather; Abhay R Satoskar; K Christopher Garcia; Christopher A Hunter; Charles G Drake; Peter J Murray; Dario A A Vignali
Journal:  Nat Immunol       Date:  2012-02-05       Impact factor: 25.606

Review 4.  The molecular details of cytokine signaling via the JAK/STAT pathway.

Authors:  Rhiannon Morris; Nadia J Kershaw; Jeffrey J Babon
Journal:  Protein Sci       Date:  2018-12       Impact factor: 6.725

Review 5.  Leukemia inhibitory factor (LIF).

Authors:  Nicos A Nicola; Jeffrey J Babon
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-04       Impact factor: 7.638

Review 6.  A (selective) history of Australian involvement in cytokine biology.

Authors:  Nicos A Nicola
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

7.  The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.

Authors:  Juan M Adrian-Segarra; Natalie Schindler; Praveen Gajawada; Holger Lörchner; Thomas Braun; Jochen Pöling
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

8.  EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer.

Authors:  Suryavathi Viswanadhapalli; Yiliao Luo; Gangadhara R Sareddy; Bindu Santhamma; Mei Zhou; Mengxing Li; Shihong Ma; Rajni Sonavane; Uday P Pratap; Kristin A Altwegg; Xiaonan Li; Annabel Chang; Alejandra Chávez-Riveros; Kalarickal V Dileep; Kam Y J Zhang; Xinlei Pan; Ramachandran Murali; Marek Bajda; Ganesh V Raj; Andrew J Brenner; Vijaya Manthati; Manjeet K Rao; Rajeshwar R Tekmal; Hareesh B Nair; Klaus J Nickisch; Ratna K Vadlamudi
Journal:  Mol Cancer Ther       Date:  2019-05-29       Impact factor: 6.261

9.  Ligand-induced architecture of the leptin receptor signaling complex.

Authors:  Liliya V Mancour; Hikmat N Daghestani; Somnath Dutta; Gerwin H Westfield; Justin Schilling; Austin N Oleskie; Jeffrey F Herbstman; Steven Z Chou; Georgios Skiniotis
Journal:  Mol Cell       Date:  2012-10-11       Impact factor: 17.970

10.  Molecular dissection of human interleukin-31-mediated signal transduction through site-directed mutagenesis.

Authors:  Sabine Le Saux; François Rousseau; Fabien Barbier; Elisa Ravon; Linda Grimaud; Yannic Danger; Josy Froger; Sylvie Chevalier; Hugues Gascan
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.